Close Menu

Grahaem Brown has been appointed director of development at Celltech. Brown previously worked in drug development for 20 years at Pfizer, Pharmacia, Novartis, and GlaxoSmithKline. Prior to that, he worked in hospital medicine for 10 years, including two years in Malaysia. He is qualified in medicine at University College Hospital in London, and has been accredited in internal and tropical medicine.

Patrick Round, previous director of development at Celltech, has become global director for CDP 870.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Nature News reports on how meeting cancellations and related costs are affecting scientific societies.

In a new ruling, Canada's Supreme Court upheld the country's genetic non-discrimination law, the Canadian Press reports.

COVID-19 vaccine developers aim to avoid a complication that has affected efforts to develop vaccines for other diseases, the Wall Street Journal reports.

In PLOS this week: analysis of insertions throughout Shigella genomes, antigen production in malaria parasites, and more.